Colorectal Cancer Trial, Recruiting NCT05903885 Sponsor: University of Nebraska Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT05903885
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who identify as Black or African American
  • People between 45 and 75 years old
  • People who are not current with recommended colorectal cancer screening (confirm with trial site for specific guidelines)
  • People who are willing to provide contact details for follow-up communication
  • People who can speak, read, and write in English
  • People who currently live in Douglas County, Nebraska

Who may not be able to join:

  • People who have previously been diagnosed with colorectal cancer
  • People who have a history of adenomas (growths in the bowel that could become cancerous) or inflammatory bowel disease (a condition causing ongoing inflammation in the digestive tract)
  • People who have a family history of colorectal cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jungyoon Kim, PhD, University of Nebraska

Phone: (402) 552-7235

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Nebraska
Registry
ClinicalTrials.gov
Start date
2 October 2023
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Fecal Immunochemical Test Kit Return Rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov